Circulation Research, Vol 70, 1191-1197, Copyright © 1992 by American Heart Association

ARTICLES

Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium

CM Boulanger, FC Tanner, ML Bea, AW Hahn, A Werner and TF Luscher
Department of Research, University Hospital, Basel, Switzerland.

Experiments were designed to examine the effect of oxidized low density lipoproteins (Ox-LDLs) on the expression and the release of endothelin from cultured endothelial cells and intact blood vessels. Ox-LDLs (30- 300 micrograms/ml), but not native low density lipoproteins (200 micrograms/ml), stimulated the expression of preproendothelin mRNA in porcine and human endothelial cells, leading to a time- and concentration-dependent release of the peptide into the culture medium. The Ox-LDL-stimulated release of endothelin was mimicked by acetylated low density lipoprotein and abolished by downregulation of protein kinase C by phorbol ester. In the intact porcine aorta, Ox-LDLs, but not native low density lipoproteins, also increased the release of peptide in an endothelium- and concentration-dependent manner. The maximal effect was observed at a concentration of 100 micrograms/ml. Incubation of the intact porcine aorta with the scavenger receptor antagonist dextran sulfate decreased the formation of endothelium evoked by Ox-LDLs. The Ox-LDL-stimulated production of the peptide was further augmented in the presence of thrombin (4 units/ml) and was unaffected by nitric oxide-generating compound 3-morpholinosydnonimine (10(-5) M). These results suggest that Ox-LDL may be an endogenous mediator of the augmented release of endothelin observed in hyperlipidemia and atherosclerosis. The increased production of the peptide could contribute to vasospastic events and may promote vascular smooth muscle proliferation and progression of atherosclerotic vascular disease.

This article has been cited by other articles:

				J. de Haro Miralles, E. Martinez-Aguilar, A. Florez, C. Varela, S. Bleda, and F. Acin Nitric oxide: link between endothelial dysfunction and inflammation in patients with peripheral arterial disease of the lower limbs Interactive CardioVascular and Thoracic Surgery, July 1, 2009; 9(1): 107 - 112. [Abstract] [Full Text] [PDF]

				P. Martinez-Miguel, V. Raoch, C. Zaragoza, J. M. Valdivielso, M. Rodriguez-Puyol, D. Rodriguez-Puyol, and S. Lopez-Ongil Endothelin-converting enzyme-1 increases in atherosclerotic mice: potential role of oxidized low density lipoproteins J. Lipid Res., March 1, 2009; 50(3): 364 - 375. [Abstract] [Full Text] [PDF]

				A. R. Chade, J. D. Krier, S. C. Textor, A. Lerman, and L. O. Lerman Endothelin-A Receptor Blockade Improves Renal Microvascular Architecture and Function in Experimental Hypercholesterolemia J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3394 - 3403. [Abstract] [Full Text] [PDF]

				G. Muller, R. A. Catar, B. Niemann, M. Barton, L. Knels, M. Wendel, and H. Morawietz Upregulation of endothelin receptor B in human endothelial cells by low-density lipoproteins. Experimental Biology and Medicine, June 1, 2006; 231(6): 766 - 771. [Abstract] [Full Text] [PDF]

				J. Madaric, J. Bartunek, K. Verhamme, M. Penicka, E. Van Schuerbeeck, P. Nellens, G. R. Heyndrickx, W. Wijns, M. Vanderheyden, and B. De Bruyne Hyperdynamic Myocardial Response to Beta-Adrenergic Stimulation in Patients With Chest Pain and Normal Coronary Arteries J. Am. Coll. Cardiol., October 4, 2005; 46(7): 1270 - 1275. [Abstract] [Full Text] [PDF]

				J. Rodriguez-Vita, M. Ruiz-Ortega, M. Ruperez, V. Esteban, E. Sanchez-Lopez, J. J. Plaza, and J. Egido Endothelin-1, via ETA Receptor and Independently of Transforming Growth Factor-{beta}, Increases the Connective Tissue Growth Factor in Vascular Smooth Muscle Cells Circ. Res., July 22, 2005; 97(2): 125 - 134. [Abstract] [Full Text] [PDF]

				C. P. del Villar, C. J. G. Alonso, C. A. Feldstein, L. A. Juncos, and J. C. Romero Role of Endothelin in the Pathogenesis of Hypertension Mayo Clin. Proc., January 1, 2005; 80(1): 84 - 96. [Abstract] [PDF]

				H. F. Galley and N. R. Webster Physiology of the endothelium Br. J. Anaesth., July 1, 2004; 93(1): 105 - 113. [Abstract] [Full Text] [PDF]

				I. Eskurza, K. D. Monahan, J. A. Robinson, and D. R. Seals Ascorbic acid does not affect large elastic artery compliance or central blood pressure in young and older men Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1528 - H1534. [Abstract] [Full Text] [PDF]

				I. A. Mawji, G. B. Robb, S. C. Tai, and P. A. Marsden Role of the 3'-Untranslated Region of Human Endothelin-1 in Vascular Endothelial Cells: CONTRIBUTION TO TRANSCRIPT LABILITY AND THE CELLULAR HEAT SHOCK RESPONSE J. Biol. Chem., March 5, 2004; 279(10): 8655 - 8667. [Abstract] [Full Text] [PDF]

				S. Rich and V. V. McLaughlin Endothelin Receptor Blockers in Cardiovascular Disease Circulation, November 4, 2003; 108(18): 2184 - 2190. [Abstract] [Full Text] [PDF]

				M.-W. Chien, C.-S. Chien, L.-D. Hsiao, C.-H. Lin, and C.-M. Yang OxLDL induces mitogen-activated protein kinase activation mediated via PI3-kinase/Akt in vascular smooth muscle cells J. Lipid Res., September 1, 2003; 44(9): 1667 - 1675. [Abstract] [Full Text] [PDF]

				A. Loidl, E. Sevcsik, G. Riesenhuber, H.-P. Deigner, and A. Hermetter Oxidized Phospholipids in Minimally Modified Low Density Lipoprotein Induce Apoptotic Signaling via Activation of Acid Sphingomyelinase in Arterial Smooth Muscle Cells J. Biol. Chem., August 29, 2003; 278(35): 32921 - 32928. [Abstract] [Full Text] [PDF]

				A. Nohria, L. Garrett, W. Johnson, S. Kinlay, P. Ganz, and M. A. Creager Endothelin-1 and Vascular Tone in Subjects With Atherogenic Risk Factors Hypertension, July 1, 2003; 42(1): 43 - 48. [Abstract] [Full Text] [PDF]

				R Berger and R Pacher The role of the endothelin system in myocardial infarction--new therapeutic targets? Eur. Heart J., February 2, 2003; 24(4): 294 - 296. [Full Text] [PDF]

				J. Ishii, H. Adachi, J. Aoki, H. Koizumi, S. Tomita, T. Suzuki, M. Tsujimoto, K. Inoue, and H. Arai SREC-II, a New Member of the Scavenger Receptor Type F Family, Trans-interacts with SREC-I through Its Extracellular Domain J. Biol. Chem., October 11, 2002; 277(42): 39696 - 39702. [Abstract] [Full Text] [PDF]

				H. Adachi and M. Tsujimoto FEEL-1, a Novel Scavenger Receptor with in Vitro Bacteria-binding and Angiogenesis-modulating Activities J. Biol. Chem., September 6, 2002; 277(37): 34264 - 34270. [Abstract] [Full Text] [PDF]

				K. P. Metsarinne, P. Vehmaan-Kreula, P. T. Kovanen, O. Saijonmaa, M. Baumann, Y. Wang, T. Nyman, F. Y. Fyhrquist, and K. K. Eklund Activated Mast Cells Increase the Level of Endothelin-1 mRNA in Cocultured Endothelial Cells and Degrade the Secreted Peptide Arterioscler Thromb Vasc Biol, February 1, 2002; 22(2): 268 - 273. [Abstract] [Full Text] [PDF]

				L DAGHER and K MOORE The hepatorenal syndrome Gut, November 1, 2001; 49(5): 729 - 737. [Full Text] [PDF]

				P. Poredos State-of-the-Art Review: Endothelial Dysfunction in the Pathogenesis of Atherosclerosis Clinical and Applied Thrombosis/Hemostasis, October 1, 2001; 7(4): 276 - 280. [Abstract] [PDF]

				A. MERTENS and P. HOLVOET Oxidized LDL and HDL: antagonists in atherothrombosis FASEB J, October 1, 2001; 15(12): 2073 - 2084. [Abstract] [Full Text] [PDF]

				L. E. Spieker, G. Noll, F. T. Ruschitzka, and T. F. Luscher Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future? J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1493 - 1505. [Abstract] [Full Text] [PDF]

				T. F. Luscher and M. Barton Endothelins and Endothelin Receptor Antagonists : Therapeutic Considerations for a Novel Class of Cardiovascular Drugs Circulation, November 7, 2000; 102(19): 2434 - 2440. [Abstract] [Full Text] [PDF]

				C. Cardillo, C. M. Kilcoyne, R. O. Cannon III, and J. A. Panza Increased activity of endogenous endothelin in patients with hypercholesterolemia J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1483 - 1488. [Abstract] [Full Text] [PDF]

				F. Ruschitzka, U. Moehrlen, T. Quaschning, M. Lachat, G. Noll, S. Shaw, Z. Yang, D. Teupser, T. Subkowski, M. I. Turina, et al. Tissue Endothelin-Converting Enzyme Activity Correlates With Cardiovascular Risk Factors in Coronary Artery Disease Circulation, September 5, 2000; 102(10): 1086 - 1092. [Abstract] [Full Text] [PDF]

				S. E. Orfanos, J. B. Parkerson, X. Chen, E. L. Fisher, C. Glynos, A. Papapetropoulos, R. G. Gerrity, and J. D. Catravas Reduced lung endothelial angiotensin-converting enzyme activity in Watanabe hyperlipidemic rabbits in vivo Am J Physiol Lung Cell Mol Physiol, June 1, 2000; 278(6): L1280 - L1288. [Abstract] [Full Text] [PDF]

				J. A. Grantham, J. A. Schirger, P. W. Wennberg, S. Sandberg, D. M. Heublein, T. Subkowski, and J. C. Burnett Jr Modulation of Functionally Active Endothelin-Converting Enzyme by Chronic Neutral Endopeptidase Inhibition in Experimental Atherosclerosis Circulation, April 25, 2000; 101(16): 1976 - 1981. [Abstract] [Full Text] [PDF]

				J. Galle, C. Lehmann-Bodem, U. Hubner, A. Heinloth, and C. Wanner CyA and OxLDL cause endothelial dysfunction in isolated arteries through endothelin-mediated stimulation of O2- formation Nephrol. Dial. Transplant., March 1, 2000; 15(3): 339 - 346. [Abstract] [Full Text] [PDF]

				C.-H. Chen, W. Jiang, D. P. Via, S. Luo, T.-R. Li, Y.-T. Lee, and P. D. Henry Oxidized Low-Density Lipoproteins Inhibit Endothelial Cell Proliferation by Suppressing Basic Fibroblast Growth Factor Expression Circulation, January 18, 2000; 101(2): 171 - 177. [Abstract] [Full Text] [PDF]

				S. Kobayashi, S. Maejima, T. Ikeda, and M. Nagase Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis Nephrol. Dial. Transplant., January 1, 2000; 15(1): 65 - 70. [Abstract] [Full Text] [PDF]

				H. Massaeli, C. Hurtado, J. A. Austria, and G. N. Pierce Oxidized low-density lipoprotein induces cytoskeletal disorganization in smooth muscle cells Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H2017 - H2025. [Abstract] [Full Text] [PDF]

				H. Xie, J. A. Bevan, and W. G. Mayhan Oxidized Low-Density Lipoprotein Enhances Myogenic Tone in the Rabbit Posterior Cerebral Artery Through the Release of Endothelin-1 • Editorial Comment Stroke, November 1, 1999; 30 (11): 2423 - 2430. [Abstract] [Full Text] [PDF]

				N. de las Heras, P. Aragoncillo, R. Maeso, S. Vazquez-Perez, J. Navarro-Cid, M. DeGasparo, J. Mann, L. M. Ruilope, V. Cachofeiro, and V. Lahera AT1 Receptor Antagonism Reduces Endothelial Dysfunction and Intimal Thickening in Atherosclerotic Rabbits Hypertension, October 1, 1999; 34(4): 969 - 975. [Abstract] [Full Text] [PDF]

				A. Lafont, E. Durand, J. L. Samuel, B. Besse, F. Addad, B. I. Levy, M. Desnos, C. Guerot, and C. M. Boulanger Endothelial Dysfunction and Collagen Accumulation : Two Independent Factors for Restenosis and Constrictive Remodeling After Experimental Angioplasty Circulation, September 7, 1999; 100(10): 1109 - 1115. [Abstract] [Full Text] [PDF]

				T. J. Anderson Assessment and treatment of endothelial dysfunction in humans J. Am. Coll. Cardiol., September 1, 1999; 34(3): 631 - 638. [Full Text] [PDF]

				G. G. Nussdorfer, G. P. Rossi, L. K. Malendowicz, and G. Mazzocchi Autocrine-Paracrine Endothelin System in the Physiology and Pathology of Steroid-Secreting Tissues Pharmacol. Rev., September 1, 1999; 51(3): 403 - 438. [Abstract] [Full Text] [PDF]

				M. Barton, C. C. Haudenschild, L. V. d'Uscio, S. Shaw, K. Munter, and T. F. Luscher Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice PNAS, November 24, 1998; 95(24): 14367 - 14372. [Abstract] [Full Text] [PDF]

				R. R. Wenzel, M. Fleisch, S. Shaw, G. Noll, U. Kaufmann, R. Schmitt, C. R. Jones, M. Clozel, B. Meier, and T. F. Luscher Hemodynamic and Coronary Effects of the Endothelin Antagonist Bosentan in Patients With Coronary Artery Disease Circulation, November 24, 1998; 98(21): 2235 - 2240. [Abstract] [Full Text] [PDF]

				B. Geny, F. Piquard, J. Lonsdorfer, and P. Haberey Endothelin and heart transplantation Cardiovasc Res, September 1, 1998; 39(3): 556 - 562. [Full Text] [PDF]

				S.-e. Chow, R.-s. Lee, S. H. Shih, and J.-k. Chen Oxidized LDL promotes vascular endothelial cell pinocytosis via a prooxidation mechanism FASEB J, July 1, 1998; 12(10): 823 - 830. [Abstract] [Full Text]

				C. J. McKenna, S. E. Burke, T. J. Opgenorth, R. J. Padley, L. J. Camrud, A. R. Camrud, J. Johnson, P. J. Carlson, A. Lerman, D. R. Holmes Jr, et al. Selective ETA Receptor Antagonism Reduces Neointimal Hyperplasia in a Porcine Coronary Stent Model Circulation, June 30, 1998; 97(25): 2551 - 2556. [Abstract] [Full Text] [PDF]

				D. B. Cines, E. S. Pollak, C. A. Buck, J. Loscalzo, G. A. Zimmerman, R. P. McEver, J. S. Pober, T. M. Wick, B. A. Konkle, B. S. Schwartz, et al. Endothelial Cells in Physiology and in the Pathophysiology of Vascular Disorders Blood, May 15, 1998; 91(10): 3527 - 3561. [Full Text] [PDF]

				E. Wight, C. F. Kung, P. Moreau, H. Takase, and T. F. Luscher Chronic Blockade of Nitric Oxide-Synthase and Endothelin Receptors During Pregnancy in the Rat: Effect on Pregnancy Outcome Reproductive Sciences, May 1, 1998; 5(3): 132 - 139. [Abstract] [PDF]

				P. A. Kaufmann, J. Frielingsdorf, L. Mandinov, C. Seiler, R. Hug, and O. M. Hess Reversal of Abnormal Coronary Vasomotion by Calcium Antagonists in Patients With Hypercholesterolemia Circulation, April 14, 1998; 97(14): 1348 - 1354. [Abstract] [Full Text] [PDF]

				S. R. Orth, J. P. Esslinger, K. Amann, U. Schwarz, M. Raschack, and E. Ritz Nephroprotection of an ETA-Receptor Blocker (LU 135252) in Salt-Loaded Uninephrectomized Stroke-Prone Spontaneously Hypertensive Rats Hypertension, April 1, 1998; 31(4): 995 - 1001. [Abstract] [Full Text] [PDF]

				E. Thorin, P. Cernacek, and J. Dupuis Endothelin-1 Regulates Tone of Isolated Small Arteries in the Rat : Effect of Hyperendothelinemia Hypertension, April 1, 1998; 31(4): 1035 - 1041. [Abstract] [Full Text] [PDF]

				L. Zhao and R. L. Tackett Oxidized Low-Density Lipoprotein Inhibits Acetylcholine-Induced Vasorelaxation and Increases 5-HT-Induced Vasoconstriction in Isolated Human Saphenous Vein J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 637 - 643. [Abstract] [Full Text]

				E. Thorin, T.-D. Nguyen, A. Bouthillier, and F. M. Faraci Control of Vascular Tone by Endogenous Endothelin-1 in Human Pial Arteries • Editorial Comment Stroke, January 1, 1998; 29(1): 175 - 180. [Abstract] [Full Text] [PDF]

				H. Adachi, M. Tsujimoto, H. Arai, and K. Inoue Expression Cloning of a Novel Scavenger Receptor from Human Endothelial Cells J. Biol. Chem., December 12, 1997; 272(50): 31217 - 31220. [Abstract] [Full Text] [PDF]

				M. Barton, F. Cosentino, R. P. Brandes, P. Moreau, S. Shaw, and T. F. Luscher Anatomic Heterogeneity of Vascular Aging : Role of Nitric Oxide and Endothelin Hypertension, October 1, 1997; 30(4): 817 - 824. [Abstract] [Full Text]

				E. Thorin, S. M. Shreeve, N. Thorin-Trescases, and J. A. Bevan Reversal of Endothelin-1 Release by Stimulation of Endothelial {alpha}2-Adrenoceptor Contributes to Cerebral Vasorelaxation Hypertension, October 1, 1997; 30(4): 830 - 836. [Abstract] [Full Text]

				V. Mathew, C. R. Cannan, V. M. Miller, D. A. Barber, D. Hasdai, R. S. Schwartz, D. R. Holmes Jr, and A. Lerman Enhanced Endothelin-Mediated Coronary Vasoconstriction and Attenuated Basal Nitric Oxide Activity in Experimental Hypercholesterolemia Circulation, September 16, 1997; 96(6): 1930 - 1936. [Abstract] [Full Text]

				T. Minamino, H. Kurihara, M. Takahashi, K. Shimada, K. Maemura, H. Oda, T. Ishikawa, T. Uchiyama, K. Tanzawa, and Y. Yazaki Endothelin-Converting Enzyme Expression in the Rat Vascular Injury Model and Human Coronary Atherosclerosis Circulation, January 7, 1997; 95(1): 221 - 230. [Abstract] [Full Text]

				M. Kusuhara, A. Chait, A. Cader, and B. C. Berk Oxidized LDL Stimulates Mitogen-Activated Protein Kinases in Smooth Muscle Cells and Macrophages Arterioscler Thromb Vasc Biol, January 1, 1997; 17(1): 141 - 148. [Abstract] [Full Text]

				H. Itabe, H. Yamamoto, M. Suzuki, Y. Kawai, Y. Nakagawa, A. Suzuki, T. Imanaka, and T. Takano Oxidized Phosphatidylcholines That Modify Proteins. ANALYSIS BY MONOCLONAL ANTIBODY AGAINST OXIDIZED LOW DENSITY LIPOPROTEIN J. Biol. Chem., December 27, 1996; 271(52): 33208 - 33217. [Abstract] [Full Text] [PDF]

				S. Ravalli, M. Szabolcs, A. Albala, R. E. Michler, and P. J. Cannon Increased Immunoreactive Endothelin-1 in Human Transplant Coronary Artery Disease Circulation, November 1, 1996; 94(9): 2096 - 2102. [Abstract] [Full Text]

				C. R. Bacon, N. R.B. Cary, and A. P. Davenport Endothelin Peptide and Receptors in Human Atherosclerotic Coronary Artery and Aorta Circ. Res., October 1, 1996; 79(4): 794 - 801. [Abstract] [Full Text]

				A. Lerman, D. R. Holmes Jr, M. R. Bell, K. N. Garratt, R. A. Nishimura, and J. C. Burnett Jr Endothelin in Coronary Endothelial Dysfunction and Early Atherosclerosis in Humans Circulation, November 1, 1995; 92(9): 2426 - 2431. [Abstract] [Full Text]

				K. P. Moore, V. Darley-Usmar, J. Morrow, and L. J. Roberts II Formation of F2-Isoprostanes During Oxidation of Human Low-Density Lipoprotein and Plasma by Peroxynitrite Circ. Res., August 1, 1995; 77(2): 335 - 341. [Abstract] [Full Text]

				J. A. Berliner, M. Navab, A. M. Fogelman, J. S. Frank, L. L. Demer, P. A. Edwards, A. D. Watson, and A. J. Lusis Atherosclerosis: Basic Mechanisms : Oxidation, Inflammation, and Genetics Circulation, May 1, 1995; 91(9): 2488 - 2496. [Abstract] [Full Text]

				A. M. Zeiher, H. Goebel, V. Schachinger, and C. Ihling Tissue Endothelin-1 Immunoreactivity in the Active Coronary Atherosclerotic Plaque : A Clue to the Mechanism of Increased Vasoreactivity of the Culprit Lesion in Unstable Angina Circulation, February 15, 1995; 91(4): 941 - 947. [Abstract] [Full Text]